These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 6192690
1. [Treatment of advanced prostatic carcinoma using estramustinphosphate]. Ferrer Roda J. Actas Urol Esp; 1983; 7(1):29-34. PubMed ID: 6192690 [No Abstract] [Full Text] [Related]
2. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)]. Lancina Martín JA, Chantada Abal V, Lamas Meilan AC, González Martín M. Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487 [No Abstract] [Full Text] [Related]
3. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study]. Trykker HU. Ugeskr Laeger; 1985 Oct 14; 147(42):3310-2. PubMed ID: 4082315 [No Abstract] [Full Text] [Related]
4. Treatment of advanced oestrogen-resistant prostatic carcinoma with estramustine phosphate. Wong AL, McGeorge A, Abel BJ. Clin Oncol; 1981 Jun 14; 7(2):163-5. PubMed ID: 7249439 [No Abstract] [Full Text] [Related]
5. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer]. Köller A, Lunglmayr G. Wien Med Wochenschr; 1983 Jun 14; 133(7):179-81. PubMed ID: 6868629 [No Abstract] [Full Text] [Related]
11. [Total remission of prostatic cancer following treatment with Estracyt]. Romics I. Orv Hetil; 1982 Jan 31; 123(5):287-9. PubMed ID: 7063244 [No Abstract] [Full Text] [Related]
12. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt]. Németh A, Morvay J, Vécsei B. Orv Hetil; 1981 Apr 26; 122(17):1017-20. PubMed ID: 7022313 [No Abstract] [Full Text] [Related]
14. [Estracit in the therapy of prostatic carcinoma]. Oresić V, Nola P, Mrsić Z, Pasini J. Acta Chir Iugosl; 1980 Apr 26; 27 Suppl 1():587-9. PubMed ID: 7424445 [No Abstract] [Full Text] [Related]
15. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer]. Nishio S, Kishimoto T, Maekawa M, Kawakita J, Hayahara N, Yuki K, Morikawa Y, Yasumoto R, Kato Y, Funai K. Hinyokika Kiyo; 1986 Nov 26; 32(11):1763-70. PubMed ID: 3825823 [Abstract] [Full Text] [Related]
16. [Use of Estracyt in cases of prostatic neoplasms]. Wesolowski S, Czaplicki M, Cieślak A. Pol Przegl Chir; 1976 Jun 26; 48(6A):783-9. PubMed ID: 951325 [No Abstract] [Full Text] [Related]
18. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)]. Rambausek M, Lutherer S, Terhorst B. Urologe A; 1981 Jul 26; 20(4):223-7. PubMed ID: 7196632 [Abstract] [Full Text] [Related]
19. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer. Benson RC, Cummings K. Prog Clin Biol Res; 1989 Jul 26; 303():177-86. PubMed ID: 2674984 [No Abstract] [Full Text] [Related]
20. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer]. Murase T, Mitsuya H, Honda N, Fukatu H, Aota Y, Shinoda M, Yoshida K, Sobajima T, Ohishi M, Tsumura Y. Hinyokika Kiyo; 1989 Jan 26; 35(1):179-85. PubMed ID: 2729015 [Abstract] [Full Text] [Related] Page: [Next] [New Search]